Association For Molecular Pathology et al v. United States Patent and Trademark Office et al

Filing 108

RULE 7.1 CORPORATE DISCLOSURE STATEMENT. No Corporate Parent. Document filed by National Organization for Rare Disorders.(Shtilerman, Mark)

Download PDF
Association For Molecular Pathology et al v. United States Patent and Trademark Office et al Doc. 108 UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF NEW YORK - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -X ASSOCIATION FOR MOLECULAR : PATHOLOGY et al., : : Plaintiffs, : vs. : : UNITED STATES PATENT AND TRADEMARK : OFFICE; et al., : : Defendants. : - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -X 09-CV-4515 (RWS) ECF DISCLOSURE STATEMENT PURSUANT TO FED. R. CIV. P. 7.1 Amicus Curiae National Organization for Rare Disorders, pursuant to Federal Rule of Civil Procedure 7.1(a), states that it has no parent corporation, and that no publicly-held corporation owns 10% or more of its stock. Dated: August 27, 2009 DEWEY & LEBOEUF LLP By: /s/ Mark D. Shtilerman Barbara A. Caulfield (pending pro hac vice) Michael J. Malecek (pending pro hac vice) Stephen C. Holmes (pending pro hac vice) Mark D. Shtilerman Dewey & LeBoeuf LLP 1301 Avenue of Americas New York, NY 10019-6092 212-259-8000 (phone) 212-259-6333 (fax) bcaulfield@dl.com mmalecek@dl.com sholmes@dl.com mshtilerman@dl.com Attorneys for Amicus Curiae National Organization for Rare Disorders Dockets.Justia.com

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?